Close

Galena (GALE) Receives Patent for NeuVax in Australia

February 28, 2014 7:20 AM EST Send to a Friend
Galena Biopharma (Nasdaq: GALE) announced that it has received a Notice of Acceptance from the Australian Patent Office for a ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login